NFE2L2 and breast cancer: Taken that hereditary mutations in breast cancer, as well as conventional cancer treatment strategies, such as chemo- and radiotherapy, cause increases in ROS, which can, in turn, cause lipid peroxidation and HNE formation, these oxidative processes may affect numerous signaling molecules such as HNE activation of NRF2 transcription factor.